share_log

ProKidney Shares Were Trading Higher After the Company Announced the Publication of the Trial Design and Early Data Analysis From REGEN-003 in the Journal of Blood Purification.

ProKidney Shares Were Trading Higher After the Company Announced the Publication of the Trial Design and Early Data Analysis From REGEN-003 in the Journal of Blood Purification.

在公司宣布在《血液净化杂志》上发表 REGEN-003 的试验设计和早期数据分析后,ProKidny 股价上涨。
Benzinga Real-time News ·  2023/01/11 12:28

ProKidney shares were trading higher after the company announced the publication of the trial design and early data analysis from REGEN-003 in the Journal of Blood Purification.

ProKidny宣布在《血液净化杂志》上发表 REGEN-003 的试验设计和早期数据分析后,ProKidny的股价走高。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发